Kymera Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Baker Bros. Advisors LP(9.8%),Baker Bros. Advisors (GP) LLC(9.8%), etc.
Apr 1 09:01 ET
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BAKER BROS. ADVISORS LP
Apr 1 09:01 ET
Kymera Therapeutics | 3: Initial statement of beneficial ownership of securities-Director BAKER BROS. ADVISORS LP
Apr 1 08:56 ET
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Booth Bruce
Mar 15 19:27 ET
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Atlas Venture Fund X, L.P.
Mar 13 19:55 ET
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Booth Bruce
Mar 13 19:55 ET
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gollob Jared
Mar 4 18:26 ET
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Chadwick Jeremy G
Mar 4 18:21 ET
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Chiniara Ellen
Mar 4 18:17 ET
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mainolfi Nello
Mar 4 18:16 ET
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jacobs Bruce N.
Mar 4 18:16 ET
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gollob Jared
Feb 29 22:32 ET
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Albers Jeffrey W.
Feb 21 18:52 ET
Kymera Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avoro Capital Advisors LLC(6.8%),Behzad Aghazadeh(6.8%)
Feb 14 09:17 ET
Kymera Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(6.73%)
Feb 13 22:47 ET
Kymera Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. ROWE PRICE ASSOCIATES, INC.(10.1%)
Feb 12 10:09 ET
Kymera Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. ROWE PRICE ASSOCIATES, INC.(9.6%)
Feb 12 10:05 ET
Kymera Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gollob Jared
Feb 9 19:50 ET
Kymera Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Atlas Venture Fund X, L.P.(8.4%),Atlas Venture Associates X, L.P.(8.4%), etc.
Feb 9 16:06 ET
Kymera Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Wellington Management Group LLP(8.68%),Wellington Group Holdings LLP(8.68%), etc.
Feb 8 10:26 ET
No Data
No Data